|
SAMD9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024820E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.355800E-02 |
| Normal-vs-Stage2 |
8.234200E-01 |
| Normal-vs-Stage3 |
1.019250E-01 |
| Normal-vs-Stage4 |
3.896000E-01 |
| Stage1-vs-Stage2 |
1.424430E-01 |
| Stage1-vs-Stage3 |
9.959200E-01 |
| Stage1-vs-Stage4 |
4.147200E-01 |
| Stage2-vs-Stage3 |
2.347000E-01 |
| Stage2-vs-Stage4 |
5.755200E-01 |
| Stage3-vs-Stage4 |
4.683600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.012500E-02 |
| Normal-vs-AfricanAmerican |
1.503000E-01 |
| Normal-vs-Asian |
1.502560E-01 |
| Caucasian-vs-AfricanAmerican |
8.768600E-01 |
| Caucasian-vs-Asian |
7.605400E-01 |
| AfricanAmerican-vs-Asian |
7.315600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.817600E-01 |
| Normal-vs-Female |
8.043900E-02 |
| Male-vs-Female |
3.196800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.761610E-02 |
| Normal-vs-Age(41-60Yrs) |
2.406600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.926000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.200000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.948400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.440400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.494100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.222400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.312200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.158600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.367200E-01 |
| Classical-VS-Follicular |
4.01080002543353E-09 |
| Classical-VS-Other |
3.314200E-02 |
| Classical-VS-Normal |
8.717800E-03 |
| Tall-VS-Follicular |
7.663100E-03 |
| Tall-VS-Other |
7.380500E-03 |
| Tall-VS-Normal |
7.196300E-02 |
| Follicular-VS-Other |
6.134400E-01 |
| Follicular-VS-Normal |
1.227800E-01 |
| Other-VS-Normal |
2.529200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.914000E-01 |
| Normal-vs-N1 |
3.998800E-01 |
| N0-vs-N1 |
9.634200E-01 |
|
|
